Clinical evidence of interaction between clopidogrel and proton pump inhibitors

doi:10.4330/wjc.v3.i5.153

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3974)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

362

HTML

3194

Figures (1-1)

221

Tables (1-2)

197

Sum=3974

May 26, 2011 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines Clinical Practice

World J Cardiol. May 26, 2011; 3(5): 153-164
Published online May 26, 2011. doi: 10.4330/wjc.v3.i5.153

Open in New Tab Full Size Figure Download Figure

Figure 1 Metabolism of clopidogrel. Clopidogrel undergoes two-step metabolism that can involve several different cytochrome P450 enzymes (from[29], reproduced with permission from the publisher of Annals of Pharmacotherapy, Copyright 2011).

Citation: Lin SL, Chang HM, Liu CP, Chou LP, Chan JW. Clinical evidence of interaction between clopidogrel and proton pump inhibitors. World J Cardiol 2011; 3(5): 153-164
URL: https://www.wjgnet.com/1949-8462/full/v3/i5/153.htm
DOI: https://dx.doi.org/10.4330/wjc.v3.i5.153